Trial record 1 of 1 for:
STEMNESS-PANC
A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03721744 |
|
Recruitment Status :
Recruiting
First Posted : October 26, 2018
Last Update Posted : April 3, 2024
|
Sponsor:
1Globe Health Institute LLC
Information provided by (Responsible Party):
1Globe Biomedical Co., Ltd. ( 1Globe Health Institute LLC )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | March 2025 |
| Estimated Study Completion Date : | September 2025 |